Study: Combo reduces risk of kidney disease for diabetics

02/20/2009 | Yahoo!

Type 2 diabetics who received a combination of blood-pressure drugs perindopril and indapamide were at lower risk of developing kidney disease than those who took placebo, according to an analysis of a clinical trial involving more than 11,000 patients. The combination treatment proved effective in reducing the risk in patients with hypertension as well as those with normal blood pressure.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA